Study supports potential for injectable chemical vaccine for malaria using atovaquone

Johns Hopkins researchers looking to develop a long-acting, injectable malaria preventive using atovaquone have shown in a new study that resistance may not be the challenge scientists thought it was, particularly when using atovaquone as a malaria preventive. Malaria parasites in infected patients being treated with atovaquone tend to develop a resistance to the drug. Because of this, atovaquone by […]

» Read more

Researchers solve mystery behind antibiotic-resistant C. difficile infection

Researchers at the Texas A&M University Health Science Center (Texas A&M Health) have uncovered why C. diff (also known as Clostridioides difficile or C. difficile) infection has developed resistance to the antibiotic metronidazole. C. diff is a bacterium that infects the colon and causes diarrhea and colitis, or inflammation of the colon. It causes almost half a million infections in […]

» Read more

Researchers document dramatic increase in cervical cancer in Appalachian Kentucky

While the overall incidence and death rates from cervical cancer have dropped in the U.S., the opposite has been occurring in Appalachian Kentucky—a steady increase. The death rate from cervical cancer in Appalachian Kentucky is now twice that of the national rate. A team of cancer population scientists from MUSC Hollings Cancer Center and the University of Kentucky Markey Cancer […]

» Read more

Children's Mercy makes progress advancing pediatric genomics

To diagnose and solve pediatric diseases, Children’s Mercy Kansas City’s has been performing whole-genome sequencing tests. Recently the hospital announced that it is the first healthcare organization to bring genetic testing bedside, says Dr. Tomi Pastinen, director of Center for Pediatric Genomic Medicine. Meanwhile, the cost of genetic and genomic testing has been coming down with its role in the standard of care for […]

» Read more

FDA Approves Tirzepatide for Treating Obesity

The US Food and Drug Administration (FDA) has approved tirzepatide for chronic weight management in adults with obesity or overweight. Eli Lilly & Company will market tirzepatide injections for weight management under the trade name Zepbound. It was approved in May 2022 for treating type 2 diabetes. The new indication is for adults with either obesity, defined as a body […]

» Read more

Risk of viral airborne transmission peaks within five seconds of face-to-face encounters, study finds

The main transmission routes identified initially for the novel coronavirus infection were droplet and contact transmission. Airborne transmission by aerosol particles was eventually identified as one of the most likely transmission routes. Especially with the relaxation of behavioral restrictions, infections continued to prevail, making prevention and risk reduction during public transportation a major challenge. In this study, researchers identified the […]

» Read more
1 23 24 25 26 27 1,330